Improving Post-Prandial Blood Glucose Control With Afrezza During Closed-Loop Therapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The study will be conducted in two phases; an in-patient meal study phase (Phase I) and an outpatient home study (Phase II). The two phase study design is chosen to enhance safety by testing the Afrezza Closed-Loop (CL) system in controlled in-clinic setting under study staff supervision before it could be investigated at the outpatient home setting. Phase II will not begin without the establishment of safety in Phase I.
Epistemonikos ID: 3ea4b9da756ed60ab377a4337d025838c41f2f17
First added on: May 21, 2024